$ALMS
Alumis Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · South San Francisco, CA
ALMS chart
What traders are saying about $ALMS
Latest postsAlumis Inc. news
- PASI 100 Rates and Site-Specific Responses With Oral Psoriasis Therapies
Dermatology Times ·
- Technical Reactions to ALMS Trends in Macro Strategies
Stock Traders Daily ·
- Alumis 2Q Loss $142.2M >ALMS
Moomoo ·
- Iovance Biotherapeutics (IOVA) Reports Q3 Loss, Beats Revenue Estimates
Yahoo Finance ·
- ALMS Q3'26 Earnings: revenue estimate is 1.90M USD
TradingView ·
- Alumis chief legal officer Sanam Pangali sells $2,164 in stock
Investing.com ·
- Alumis CDO Mark Christopher Bradley Executes Sell-to-Cover of 623 Shares
Kalkine Media ·
- Tax-cover sale at Alumis (ALMS): Goldstein sells 629 shares under mandatory policy.
Stock Titan ·
- Alumis Inc. (ALMS) Seasonal returns chart
Yahoo Finance UK ·
- Alumis snags set of Phase III psoriasis pill victories, but analysts lukewarm on impact
clinicaltrialsarena.com ·
- Alumis Announces New Phase 3 Data Demonstrating Envudeucitinib Rapidly and Durably Improved Psoriasis Burden Across Scalp, Itch, and Quality of Life Measures
Yahoo Finance ·
- Aardvark Therapeutics Appoints Clinical Development Leader David Zhang, Ph.D., MBA, to its Board of Directors
Yahoo Finance ·
Alumis Inc. key financials
| USD | 2025 | 2024 | 2023 |
|---|---|---|---|
| Revenue | $24.1M | – | – |
| Net income | -$243.3M | -$294.2M | -$155.0M |
| Diluted EPS | $-2.86 | $-10.38 | $-72.08 |
| Total assets (year end) | $411.9M | $341.0M | $89.6M |
| Cash and equivalents (year end) | $89.7M | $169.5M | $46.0M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Alumis Inc.
- Ticker
- ALMS (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- South San Francisco, CA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1847367
- Former names
- FL2021-001, Inc.
Frequently asked questions
What exchange is Alumis Inc. listed on?
Alumis Inc. trades on the Nasdaq under the ticker symbol ALMS.
What industry is Alumis Inc. in?
Alumis Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Alumis Inc. headquartered?
Alumis Inc.'s business address on file with the SEC is in South San Francisco, CA.
When does Alumis Inc.'s fiscal year end?
Alumis Inc.'s fiscal year ends on December 31.
How much revenue did Alumis Inc. report?
Alumis Inc. reported $24.1M in revenue for calendar year 2025, according to its SEC filings.